Abstract
Chryseobacterium species are gaining importance as an emerging opportunistic nosocomial pathogen. Limited availability of clinical data necessitates reporting of such isolates. We report a case of nosocomial urinary tract infection by metallo-β-lactamase-producing Chryseobacterium gleum in an elderly diabetic male with chronic renal disease. Identification and antibiotic sensitivity test performed by conventional methods were confirmed by Matrix-assisted Laser Desorption Ionization Time-of-Flight and VITEK-2 systems, respectively. The patient responded well to intravenous ciprofloxacin therapy.
MeSH terms
-
Anti-Bacterial Agents / administration & dosage
-
Bacterial Typing Techniques
-
Chryseobacterium / classification
-
Chryseobacterium / drug effects
-
Chryseobacterium / enzymology
-
Chryseobacterium / isolation & purification*
-
Ciprofloxacin / administration & dosage
-
Diabetes Complications
-
Flavobacteriaceae Infections / diagnosis*
-
Flavobacteriaceae Infections / drug therapy
-
Flavobacteriaceae Infections / microbiology*
-
Flavobacteriaceae Infections / pathology
-
Humans
-
Kidney Diseases / complications
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
-
Treatment Outcome
-
Urinary Tract Infections / diagnosis*
-
Urinary Tract Infections / drug therapy
-
Urinary Tract Infections / microbiology*
-
Urinary Tract Infections / pathology
-
beta-Lactamases / metabolism
Substances
-
Anti-Bacterial Agents
-
Ciprofloxacin
-
beta-Lactamases